Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox–Gastaut syndrome, ESES: A functional framework

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Orrin Devinsky, J. Helen Cross, Linda Laux et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

Orrin Devinsky, Anup D. Patel, J. Helen Cross et al. · New England Journal of Medicine · 2018 · 977 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 887 citations

Medicine, Neurology, Pharmacology +9

Developing and validating the Communication Function Classification System for individuals with cerebral palsy

Mary Jo Cooley Hidecker, Nigel Paneth, Peter Rosenbaum et al. · Developmental Medicine & Child Neurology · 2011 · 865 citations · Full text

Education, Special Education, Speech-language Pathology +16

<i>KCNQ2</i> encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy

Sarah Weckhuysen, Simone Mandelstam, Arvid Suls et al. · Annals of Neurology · 2011 · 514 citations

Medicine, Genetics, Neurology +17